chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Headache, fatigue, chills, body aches, onset: 1/7/2021. As of today, 1/12/2021, I have experienced a persistent temporal headache that has not responded to OTC medications including: ibuprofen, tylenol, and excedrin.
bumps extend across his whole neck; liquid comes out before the blood. The pimples have not resolved; pimples on neck/ pimples have not resolved; This case was reported by a consumer via call center representative and described the occurrence of papular rash in a 60-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 22nd July 2021, the patient received the 1st dose of Shingrix (intramuscular). On 23rd July 2021, 1 days after receiving Shingrix, the patient experienced papular rash, pustular acne and pimples. On an unknown date, the outcome of the papular rash, pustular acne and pimples were not recovered/not resolved.   It was unknown if the reporter considered the papular rash, pustular acne and pimples to be related to Shingrix.  Additional details were provided as follows: This case was reported by the patient himself. The patient received Shingrix in the left arm and developed about 50 large bumps on the back of his neck, from his hairline down. Patient reported that bumps are not itchy. The bumps extended across his whole neck from one ear to the other.  The patient stated that he could not pop them like a pimple, but he did take a needle to one and clear liquid came out before the blood.  The pimples had not resolved.  Patient will be contacting his health care professional.  The reporter did not consent to follow-up.
Dizziness Fever Pain all over the body Fatigue Discouragement Left arm swelling
Medical assistant incorrectly administered INFANRIX to patient instead of BOOSTRIX. The correct vaccine was ordered in EMR by physician. The correct vaccine was discussed with medical assistant, parent and patient.
L thigh local reaction 2 x 2cm tender, warm macule, edema.
2/26/2003 Painful bullous rash on skin and mucous membranes.  3/1/2003 Fevers, conjunctivitis, malaise, myalgias, central headache. Diagnosed with Steven's Johnson Syndrome. Annual follow up on 03/30/04: "Pt has recovered from adverse events."
Headache, Sedation, Rash Injection site reaction Narrative: Evening after injection employee experienced headache, fatigue, and soreness at injection site. A burning and itching rash first appeared on left buttock cheek on 02/25/2021 (was not reported because thought to be a bug bite). Rash then reappeared 03/01/2021 on multiple areas: both shoulders, injection site, left lower back, right back of forearm.
On Monday evening, client "could not hold food" but denied diarrhea. Client stated that he had well formed bowel movements (most of the time) every 2-3 hours on Monday, then had 3-5 bowel movements on Tuesday. Client stated he felt a lower intestinal pain that was relieved by having a bowel movement. Client states he still felt this pain yesterday and today when he has to urinate and is relieved by urination. Client also reported feeling weak and felt his quadriceps and legs felt "strained" when he went for a hike. From Wednesday until today (Thursday) client reports feeling weak, having shivers, and sweating. Client states he has "cycles" of sweating, feeling better, shivering, feeling weak, then sweating again. Per client, he has not been able to eat well since Tuesday. He reports only being able to eat during the period of time after sweating when he feels better. Client also reports not sleeping well for the past 2 nights. Client also states he developed a cough on Tuesday.
I went to urgent care yesterday, and it is diagnosed as Shingles; She felt terrible/feel really bad; later my back started to broke out; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (She felt terrible/feel really bad), BACK PAIN (later my back started to broke out) and HERPES ZOSTER (I went to urgent care yesterday, and it is diagnosed as Shingles) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Mar-2021, the patient experienced FEELING ABNORMAL (She felt terrible/feel really bad) and BACK PAIN (later my back started to broke out). On 30-Mar-2021, the patient experienced HERPES ZOSTER (I went to urgent care yesterday, and it is diagnosed as Shingles). At the time of the report, FEELING ABNORMAL (She felt terrible/feel really bad), BACK PAIN (later my back started to broke out) and HERPES ZOSTER (I went to urgent care yesterday, and it is diagnosed as Shingles) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant product use was provided by the reporter. Treatment information was not provided.
No additional AE reported; a dose of PROQUAD was administered after a temperature excursion.; This spontaneous report has been received from a non health care professional and refers to a patient of a not reported age or gender.  The patient's medical history, concurrent conditions, concomitant therapies and previous drugs reactions or allergies were not reported.  On 06-SEP-2022, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (rHA) (PROQUAD) lot #W017570, expiration date: 29-NOV-2023, administered for prophylaxis (dose description, vaccination scheme,  and route of administration were not provided) following a temperature excursion of 5.7 degrees Farenheit (F) for 30 minutes (product storage error), it was mentioned that previous temperature excursion did occurred between 6 F up to 14 F (9.1F) for 1 hour 6 minutes; and 6F up to 14F (10F) for 1 hour 8minutes. No additional adverse event was reported.
The correct vaccine was administered but it was past its Beyond Use Date of 11-17-2022.  Patient was notified and has not experienced any trouble.
I63.9 REVERSIBLE ISCHEMIC NEUROLOGIC DEFICIT SYNDROME 4/26/2023 ATRIAL FIBRILLATION, UNSPECIFIED I63.9 REVERSIBLE ISCHEMIC NEUROLOGIC DEFICIT SYNDROME 4/26/2023 ATRIAL FIBRILLATION, UNSPECIFIED
The patient is a 72 y.o. female with history of CAD with prior PCI, CKD stage IV, uncontrolled IDDM, HTN, chronic diastolic HFpEF, HLD, peripheral artery disease, depression, overactive bladder, obesity, dementia, presented to the Medical Center with shortness of breath with exertion found to be COVID-positive on 1/24/2023.   Acute respiratory failure with hypoxia Multifocal PNA Due to COVID pneumonia, difficult to rule out secondary bacterial pneumonia but lack of leukocytosis and low PCT suggest against Small effusions on CT chest in addition to multifocal airspace disease, suggests some volume component but otherwise appears euvolemic Doubt bacterial pneumonia and UTI has been treated, no need to continue levaquin on discharge (completed 4d inpatient) See below re COVID Respiratory failure resolved, ok for discharge   Covid-19 Virus Infection CRP: 140 (1/24) Date of onset of symptoms: Circa 1/18/23 Symptoms present on admission: DOE, hypoxemia Date of covid positive test: 1/24/23 Vaccination status: vaccinated and boosted Imaging:  Cxr (1/24/23) Multifocal consolidation  CT chest same date multifocal consolidation and small-mod pleural eff b/l Baseline oxygen: None Oxygen requirements on admission: 4 liters NC Current oxygen requirements: 94% RA Medical therapy: dexamethasone, not eligible for remdesivir (CKD) Consultants following: ID Anticipated special isolation end date: 2/3/23   CAD S/P PCI HLD Troponin T: Undetected, EKG NSR without ST elevation or depression or T wave TTE 10/2020 EF 55-6% Moderate concentric LVH. Normal RV size and function.  Appeared mildly fluid overloaded on admission, now appears euvolemic Diuresis as below Resuming toprol 50 mg bid, norvasc 10 mg daily, hyralazine 100 mg TID with hold parameters Continue aspirin 81 mg daily, Atorvastatin 40 mg daily   HTN Resuming Norvasc 10 mg daily, Toprol 50 mg twice daily, hydralazine 100 mg 3 times daily   CKD Stage IV Hyperkalemia Adm K: 5.7, BUN: 68, Cr: 2.66, GFR: 19 (baseline Cr: 2.6, GFR: 21) Cr up to 3.1 after initial diuresis and resuming home torsemide Cr down to 2.7, resumed torsemide once daily (home dose twice daily) Can resume home diuretic regimen on discharge IDDMT2 Steroid induced hyperglycemia Adm Glucose: 323 A1c: 9.5 (12/29/22), EAG: 226-- on lantus 60u HS and novolog SSI Check blood sugars ac & HS; still running high Lantus to 45u BID, humalog 5/5/5 with meals and normal sensitivity SSI here Control improved Will be off steroids at discharge, resume home regimen on discharge   ESBL UTI Dx 1/20/23, w/ dysuria Discontinued cipro on 1/25, started levaquin until 1/28 for UTI  Completed course of treatment C/s ID; appreciated
She experienced itchy hives from head to toe. Denied allergy to eggs, had no reaction to 1st GARDASIL shot. This was her first flu shot. Told patient to stop ALLEGRA and take BENADRYL and call back if not relief or breathing problems.
HEADACHE; INCREASED BLOOD SUGAR; SHAKINESS; LIGHTHEADEDNESS AND DIZZINESS; SORE ARM; FEELING WARM; NAUSEA; This spontaneous report received from a patient concerned a not Hispanic/Latino Asian female of unspecified age. The patient's height, and weight were not reported. The patient's concurrent conditions included diabetes, non-alcoholic, and non-smoker, and other pre-existing medical conditions included the patient had no history of any drug abuse or illicit drug usage. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808609, expiry: UNKNOWN) dose was not reported, administered in left arm on 23-MAR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 23-MAR-2021, the subject experienced increased blood sugar. On 23-MAR-2021, the subject experienced shakiness. On 23-MAR-2021, the subject experienced lightheadedness and dizziness. On 23-MAR-2021, the subject experienced sore arm. On 23-MAR-2021, the subject experienced feeling warm. On 23-MAR-2021, the subject experienced nausea. On 24-MAR-2021, the subject experienced headache. Treatment medications (dates unspecified) included: paracetamol (Tylenol). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from shakiness, lightheadedness and dizziness, sore arm, feeling warm, increased blood sugar, nausea, and headache. This report was non-serious.; Sender's Comments: V.0 Medical assessment comment not required as per standard procedure as case was assessed as non-serious.
Information has been received from a physician via Company representative concerning to a patient of unknown age and gender. Concurrent and historical conditions were not reported. Concomitant therapies were not provided. On 20-JAN-2015, the patient was vaccinated with an improperly stored dose of GARDASIL (Lot No. K001631, exp. 06-NOV-2016) (dose and site not reported). On an unspecified dates, the GARDASIL vaccine had two temperature excursions: 336 and 108 hours respectively. The lowest recorded temperature was -3 (-3 Celsius degrees). The highest recorded temperature was 59 (15 Celsius degrees). The vaccine status was reported as "in excursion". The vaccine storage criteria and the vaccine excursion were reported as "Refrigerator (R)". No adverse effects were reported. There was no product quality complaint involved. This is one of several reports received from the same reporter. Additional information has been requested.
After first shot, I noticed stiffness and soreness in right knee but attributed it to a misstep in snow.  It was annoying but not limiting; however, muscle soreness I attributed to a wrenched knee did not abate.    At this point, I consulted my Primary Care Physican's office, and I also had an X-ray of my knee.  It showed an aging kneecap, but I continued to report pain as muscular and on the side of my knee.   An appt with local orthopedic center was suggested by PCP office and was scheduled.  This was the day before my second shot.          After my second shot, the pain and difficulty walking increased 100-fold.  Orthopedist suggested PT for next 6 weeks, which I will do.  Taking Tylenol and Ibuprofin, applying heat and cold, using some topical pain relievers; but for the most part, I am just not able to walk far, if at all.  I run a business from my home, so I get around by "riding" my rolling office chair everywhere in my (fortunately) small home.   If I can get to the car, I can drive without difficulty.             I am a busy, active, independent person.  Having experienced the polio epidemic in the '50's, I get all my vaccines; I am not anti-vaccines.  I do feel the fact that my disability happened the same month as the vaccine is significant, and I wanted you to know my symptoms and situation.
Pt report generalized muscle aches and tiredness. Then post 2+ hr immunization awaken with difficulties breathing, shortness of breath and itchy over body. Pt treated self with nebulizer treatments which decreased her difficulties in breath. Itching resolved in 2 days.
Large 3 1/2" urticarial patch over injection sites on right thigh - started at the MMR site - enlarged to cover both sites.
Arm pain and numbness radiating from the point of injection up to the top of her shoulder. Patient says arm locks and makes a clicking noise when she rotates it. She also states she developed shingles 2 months later.
Two hours after vaccination, started feeling dizzy, lightheaded and near syncope. This lasted for about 6 hours. For the following three days after vaccination had a horrible headache and nausea and episodes of lightheadedness.
10/6 at 2pm got shot. Woke 10/7 too sick to work, heavy fatigue, fever/chills, head & muscle aches all day. 10/8 fatigue, head/body aches, pain in shot location, tried to go work 1/2 day went home to rest, at 5:30pm did a 25 min. walk on treadmill, felt flush headache I took 2 aspirin and rested more. At about 830pm my heart rate noticeably elevated monitored 127/64, Taste of vax/med in mouth/sinus, Went to bed 910pm, woke up 10:45pm in severe chills/heavy sweats, left shoulder twitching, I was terrified as I couldn't move my left side of body/face, couldn't feel my left leg or move arm much, right leg tingling numb, 3hrs at 1 am finally stumbled/crawl to bathroom, and back, 10/9 woke drained, ache and limbs numb,  Arms still a little numb and tingly and weak, and fatigued all of 10/9 then each day from 10/10 fatigued and achy ,10/11, and 10/12 the symptoms slowly improved. 10/13 to current day more normal feeling. Experienced elevated heart rate a few times in the past week of-which I never get, and records show I rarely get sick..
8 1/2 year old child developed erythematous, warm about 6x8 cm area on extensor surface of left upper arm where Varivax was given. Area itchy and painful to child.
Wrong COVID-19 vaccine product administered to a pediatric patient.  Patient was 15 years old at the time of vaccination.  Was administered the Janssen J&J COVID vaccine product and should not have received this product.  (only Pfizer was approved for administration in < 18 years of age).  Reported via error reporting system:  "16Y/F with Turner's Syndrome, Hypothyroidism, Primary Ovarian Failure. She received J & J Vaccine for CV19 in Summer 2021. This Vaccine is NOT Approved in Individuals < 18 Years. Unsure how the Vaccine was administered to the Child as it is NOT FDA Approved for her age (only Pfizer was Approved). Mother reported to me at the January 2022 that the dr. Office mentioned it was okay to get the J&J vaccine when questioned at time of Scheduling. Of mention, the discussion came up as the mother was asking about recommendations for Booster for her during the Outpatient Endocrine Visit."
Date of Admission: 10/16/2022   Date of Discharge: 10/21/2022   Diagnoses on Admission Order: No associated diagnoses for current labs     Hospital Principal Problem (Discharge Diagnoses): COVID-19
Headache, NauseaVomiting, fatigue, considerable muscle aches x 18 hrs Narrative:
Myelitis transverse; This spontaneous case was reported by a nurse and describes the occurrence of MYELITIS TRANSVERSE (Myelitis transverse) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In January 2021, the patient experienced MYELITIS TRANSVERSE (Myelitis transverse) (seriousness criterion medically significant). At the time of the report, MYELITIS TRANSVERSE (Myelitis transverse) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The patient had 5 MRIs and numerous doctor's appointments since Jan-2021. The symptoms began within hours of receiving his first Moderna shot in Jan-2021.  Treatment information was not provided.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. More information has been requested.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. More information has been requested.
High temp of 103° for all nite long. Took Tylenol for comfort It started with me being ice cold, then later the hi-fever.
pretty much like having the flu; fever; aches; weakness; This case was reported by a consumer and described the occurrence of influenza-like symptoms in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced influenza-like symptoms, fever, pain and weakness. On an unknown date, the outcome of the influenza-like symptoms, fever, pain and weakness were unknown.   It was unknown if the reporter considered the influenza-like symptoms, fever, pain and weakness to be related to Shingrix.  Additional details were provided as follows: The age group was not reported but was captured as adult as per the vaccine indication. The age at vaccination was not reported. After receiving Shingrix, the patient had a pronounced reaction which included fever, aches, weakness pretty much like having the flu.
Shivering, heavy sweating, nausea, vomiting, constantly freezing-could not get warm, hallucinations, could only sleep for 20-30 minutes at a time because would wake up with clothes completely wet through including sheets-up to 6X in one night for 3 nights and 1 day duration to date, chronic muscle pain beyond normal fibromyalgia pain, migraine-type headaches, sour throat, difficulty breathing, unable to walk properly on Day 3 due to groin pain and chronic muscle weakness.   Batch/Lot number given: AFLLA599BA Exp. 6/2011 GSK.   Still extremely ill on Day 4 (10/18/2010) at 1:40 PM.
Patient received a COVID19 vaccine, however, the patient was expecting to receive a flu vaccine instead.  The error was identified by the nurse administering the vaccine.  Patient remained in the waiting area at the pharmacy for approximately 2 hours after the injection, with no visible signs or symptoms of an adverse reaction.
Information has been received from a registered pharmacist concerning a 10 year old patient who was vaccinated with a dose of ZOSTAVAX (Oka/Merck) instead of VARIVAX (Oka/Merck). This happened within the past 24 hours at a hospital physician unknown. No adverse effects known. The pharmacist was not aware it was product confusion. The grandmother indicated human error. Unspecified medical attention was sought. No product quality complaint was involved. This is one of several reports received from the same source. No further information is available.
Vaccine given March 18   Menstruation began five days early on March 20. Lasted six days. Very heavy. Unusual. Nine days after the period ended, another menstruation period began on April 2. The bleeding is VERY heavy. Very unusual as I?m in perimenopause.   Recap: since Moderna shot one period came early and then a second period nine days later. Very heavy both.
1st dose in Jan2021 and no 2nd dose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (1st dose in Jan2021 and no 2nd dose) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Sep-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (1st dose in Jan2021 and no 2nd dose). On 07-Sep-2021, PRODUCT DOSE OMISSION ISSUE (1st dose in Jan2021 and no 2nd dose) had resolved.            No concomitant product information was provided.  Treatment information was not provided.
Pt called pharmacy 11/18/2019 to report that she experienced redness, warmth and pain at the injection site overnight after influenza immunization.  She was prescribed cephalexin 500mg twice daily for 7 days on 11/17/19.
Patient with 4 COVID vaccines who admitted with positive COVID test and pulmonary embolism for hospital admission.  Provider d/c note:  "66 YO male presented with passive pulmonary embolism causing respiratory failure and circulatory failure.  Found to have covid, though likely incidental given course and imaging findings.  Treated with tpa and subsequent thrombectomy with resolution of respiratory failure.  Patient noted to have concerning right renal mass on imaging, will need Urology evaluation for nephrectomy. Pulmonary consulted, likely safe for surgery in 1 month.   Problem list: Acute respiratory failure with hypoxia - pulmonary embolism, COVID, OSA               -resolved, off supplemental O2               -home BiPAP settings when sleeping Acute pulmonary embolism               -s/p tpa 10/23, mechanical thrombectomy 10/24               -apixaban x 6  months Circulatory shock, resolved (due to pulmonary embolism) Right renal mass               -Referred for Urology evaluation, concern for RCC               -Requires a month of anticoagulation before nephrectomy is safe and anticoagulation can be held temporarily  Diabetes mellitus type 2 in morbidly obese, Body mass index is 49.02 kg/m².                -sliding scale Humalog               -resume metformin/ozempic on discharge  Hypertension               -valsartan/hydrochlorothiazide remain held with relative hypotension             -reassess with PCP "
Patient reports she received the Moderna Covid 19 vaccine lot number 039K20A on 01/06/2021 in her left deltoid. Patient received the vaccine at Center. Patient reports on 1/15/2021 she noted injection site to be red, swollen, and itchy. Patient reports she self managed with tylenol. Patient plans to continue to self monitor. VAERS completed. D/c from center
Information has been received from a health professional who states that some clients had experienced adverse events post vaccination with Gardasil.  The events included fainting, dizziness, visual changes and hot flashes.  The number of patients involved was unknown and the reporter thinks that the clients have recovered.  The reporter states that she made this call for the doctor and has no other information on the clients.  Additional information has been requested.